MNKD Message Board Post 10867894 | MannKind Corporation
home / stock / mnkd / mnkd message board
TPHOOVY
(investorshangout)
Posted on: Feb/26/2019 21:23:01
Source: investorshangout
https://investorshangout.com/post/view?id=5362237
znewcar1: 16.56% v9,824,298 c1.7600 f159,597,570 its a ugly chart
News, Short Squeeze, Breakout and More Instantly...
-
Study proves inhaled insulin is as effective as usual care (primarily automated insulin delivery pumps or multiple daily injections) for adults living with T1D meeting the primary endpoint Patients utilizing inhaled insulin reached target A1c (less than 7%) 30% of the time compared to 17%...
-
17-week endpoint results comparing Afrezza ® head-to-head with multiple daily injections (MDI) and insulin pumps INHALE-3 Study Protocol Chair Dr. Irl. B. Hirsh joined by investigational team to deliver presentation moderated by Jaeb Center founder Dr. Roy W. Beck ...
-
Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation PR Newswire Cross license involves Pulmatrix iSPERSE™ technology and MannKind's Cricket ® inhalation device. Pulmatrix transferring leased building,...